Search research articles
Contact Us
Filters
Showing results (751-760 of 779) with videos related to
Page
of 78
Sort By:
Journal for Immunotherapy of Cancer
|
March 19, 2021
Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer
Andrea Ardizzoni, Sergio Azevedo, Belen Rubio-Viqueira, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 14, 2026
Prophylactic rhTPO Prevents Cancer Therapy-Induced Thrombocytopenia During Concurrent Chemoradiotherapy in Limited-Stage SCLC:A Prospective, Multicenter, Phase II Clinical Trial
Shijiang Wang, Fen Zhao, Jin Wang, et al.
Science Advances
|
January 27, 2023
Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression
Chao Liu, Min Zhang, Xinlong Yan, et al.
Science Advances
|
October 6, 2021
ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation
Yuanqin Yang, Meng Wu, Dongqing Cao, et al.
Eclinicalmedicine
|
September 10, 2024
Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC): a phase II trial
Dawei Chen, Bing Zou, Butuo Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M-positive Non-Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study
Ligang Xing, Yueyin Pan, Yuankai Shi, et al.
Eclinicalmedicine
|
July 17, 2025
Total neoadjuvant therapy integrating long-course radiotherapy with trifluridine/tipiracil for locally advanced rectal cancer: a single-arm, multicenter phase 2 trial
Xue Dou, Lina Zhao, Zhenyu Ma, et al.
The American Journal of Pathology
|
February 23, 2019
β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma Pathogenesis
Qian Min, Laura Molina, Jing Li, et al.
British Journal of Cancer
|
October 20, 2023
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial
Xue Meng, Anping Zheng, Jun Wang, et al.
Frontiers in Oncology
|
August 1, 2022
Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer
Kewen He, Shaotong Zhang, Jiaohui Pang, et al.
Page
of 78
Search research articles
Search
Showing results (751-760 of 779) with videos related to
Sort By:
Page
of 78
Journal for Immunotherapy of Cancer
|
March 19, 2021
Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer
Andrea Ardizzoni, Sergio Azevedo, Belen Rubio-Viqueira, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 14, 2026
Prophylactic rhTPO Prevents Cancer Therapy-Induced Thrombocytopenia During Concurrent Chemoradiotherapy in Limited-Stage SCLC:A Prospective, Multicenter, Phase II Clinical Trial
Shijiang Wang, Fen Zhao, Jin Wang, et al.
Science Advances
|
January 27, 2023
Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression
Chao Liu, Min Zhang, Xinlong Yan, et al.
Science Advances
|
October 6, 2021
ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation
Yuanqin Yang, Meng Wu, Dongqing Cao, et al.
Eclinicalmedicine
|
September 10, 2024
Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC): a phase II trial
Dawei Chen, Bing Zou, Butuo Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M-positive Non-Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study
Ligang Xing, Yueyin Pan, Yuankai Shi, et al.
Eclinicalmedicine
|
July 17, 2025
Total neoadjuvant therapy integrating long-course radiotherapy with trifluridine/tipiracil for locally advanced rectal cancer: a single-arm, multicenter phase 2 trial
Xue Dou, Lina Zhao, Zhenyu Ma, et al.
The American Journal of Pathology
|
February 23, 2019
β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma Pathogenesis
Qian Min, Laura Molina, Jing Li, et al.
British Journal of Cancer
|
October 20, 2023
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial
Xue Meng, Anping Zheng, Jun Wang, et al.
Frontiers in Oncology
|
August 1, 2022
Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer
Kewen He, Shaotong Zhang, Jiaohui Pang, et al.
Page
of 78